|
| |
@allos.com Pages on BioPortfolio:
BioPortfolio - @allos.com
allos.com - BioPortfolio. ... Finance See the company profile for ALLOS THERAPEUTICS (ALTH) including business . ...
http://www.bioportfolio.com/search/@allos.com.html...
|
Biotechnology News Allos allo. 3927147. alth. 7325. pdx. propel ...
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Allos Therapeutics Incorporated
Allos Therapeutics Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/564-Allos_Therapeut...
|
Biotechnology News Anemia Refractory Search
Allos Therapeutics Reports 2008 Third Quarter Results Allos Therapeutics, Inc. ( NASDAQ: ALTH) today reported results for the third quarter of 2008. ...
http://www.bioportfolio.co.uk/Anemia%20Refractory-news.htm...
|
BioPortfolio - allos.com
allos.com - BioPortfolio. ... For more information, visit the Company's web site at www.allos.com. Safe Harbor Statement. This press release contains . ...
http://www.bioportfolio.com/search/__allos.com.html...
|
Biotechnology News Trophoblastic Neoplasms lymphoid. 674. 0369 ...
Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...
|
BioPortfolio - Allos Therapeutics Incorporated - Profile
View the current Allos Therapeutics Incorporated Page on BioPortfolio.com ... Allos Therapeutics is a biopharmaceutical company focused on developing and ...
http://www.bioportfolio.com/biocorporate/564-Allos+Therapeut...
|
Biotechnology News Bladder Cancer Search
Allos Therapeutics, Inc. (Nasdaq:ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the ...
http://www.bioportfolio.co.uk/Bladder%20Cancer-news.htm...
|
BioPortfolio - BioPortfolio - Allos Therapeutics Incorporated
BioPortfolio - Allos Therapeutics Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/linkout/564/www.all...
|
BioPortfolio - pralatrexate
Scheduled Combination of Allos Therapeutics' Pralatrexate Plus . ... For more information, visit the Company's web site at www.allos.com. ...
http://www.bioportfolio.com/search/pralatrexate.html...
|
Results from other life science and pharmaceutical sites:
BioPortfolio - Allos Therapeutics Incorporated
Allos Therapeutics Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/564-Allos_Therapeut...
|
Allos Therapeutics, Inc. Initiates Phase 2b Study of PDX in ...
7 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. today announced the initiation of patient enrollment in a Phase 2b, randomized, multi-center study
...
http://www.biospace.com/news_story.aspx?NewsEntityId=81946...
|
News: Allos Therapeutics Reports 2008 Third Quarter Results ...
Allos Therapeutics Reports 2008 Third Quarter Results. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business.
http://www.genengnews.com/news/bnitem.aspx?name=44887256&tax...
|
Allos Therapeutics, Inc. Initiates Study of RH1 in Patients with ...
"We are pleased to advance the development of this agent," said Pablo J. Cagnoni , M.D., Chief Medical Officer of Allos. "RH1 is a small molecule ...
http://www.biospace.com/news_story.aspx?NewsEntityId=77283...
|
Allos Therapeutics to Report Third Quarter 2008 Results on ...
Allos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008. - WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH ...
http://biz.yahoo.com/bw/081029/20081029005303.html...
|
Allos Therapeutics, Inc. Scraps Brain Cancer Drug After Trial ...
19 Jun 2007 ... The web cast will be available from the homepage and the investors/media section of the Company's web site at http://www.allos.com and will ...
http://www.biospace.com/news_story.aspx?NewsEntityId=60435...
|
Allos Therapeutics Reports 2008 Third Quarter Results: Financial ...
5 Nov 2008 ... Allos Therapeutics Reports 2008 Third Quarter Results. - WESTMINSTER, Colo.--( BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ: ALTH - News) ...
http://biz.yahoo.com/bw/081105/20081105005976.html?.v=1...
|
Allos Therapeutics, Inc.'s PDX Granted Orphan Medicinal Product ...
Allos Therapeutics, Inc. (ALTH) is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=52914...
|
Allos Therapeutics Reports 2008 Third Quarter Results
Allos Therapeutics, Inc. (NASDAQ: ALTH) today reported results for the third quarter of 2008. For the three months ended September 30, 2008, ...
http://www.genengnews.com/news/bnitem_print.aspx?name=448872...
|
Allos Therapeutics, Inc. Initiates Study of PDX in Patients with ...
15 /PRNewswire-FirstCall/ -- Allos Therapeutics, Inc. today announced the initiation of patient enrollment in a Phase 1, open-label, multi-center study of
...
http://www.biospace.com/news_story.aspx?NewsEntityId=66650...
|
|
